Related Experiment Video
Updated: Aug 22, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
[Epigenetic changes in breast cancer shown by aberrant promoter methylation]
U Lehmann1, F Länger, G Celikkaya
1Institut für Pathologie, Medizinische Hochschule Hannover.
Abstract:
The aberrant methylation of cytosine residues in the promoter region of growth-regulatory genes is now recognized as an important inactivation mechanism in addition to deletion and mutation in the development and progression of cancer. Principally all pathways regulating proliferation and differentiation, which are perturbed in cancer cells, can be affected. In breast cancer epigenetic inactivation is a frequent and early event displaying great quantitative gene-specific differences during progression. The occurrence of specific aberrant methylation patterns is associated with the histological grade and subtype of mammary carcinoma biopsies.
Insights
Aberrant DNA methylation of growth-regulatory genes is a key mechanism in cancer development. Specific methylation patterns in breast cancer correlate with tumor grade and subtype.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Oncology
Context:
- Aberrant methylation of cytosine residues in promoter regions is a crucial gene inactivation mechanism in cancer, alongside deletion and mutation.
- This epigenetic silencing affects proliferation and differentiation pathways critical to cancer development and progression.
- In breast cancer, epigenetic inactivation is a frequent and early event with significant gene-specific variations during disease progression.
Purpose:
- To investigate the role of aberrant DNA methylation in cancer development and progression.
- To analyze the occurrence and significance of specific aberrant methylation patterns in breast cancer.
- To associate methylation patterns with histological grade and subtype of mammary carcinoma.
Summary:
- Aberrant promoter methylation of growth-regulatory genes is an important mechanism for gene inactivation in cancer.
- Epigenetic inactivation impacts key cellular pathways, including proliferation and differentiation, which are dysregulated in cancer.
- Breast cancer frequently exhibits early epigenetic inactivation with distinct gene-specific methylation profiles that change during progression.
Impact:
- Highlights aberrant methylation as a critical factor in cancer etiology and progression.
- Establishes a link between specific epigenetic alterations and breast cancer characteristics.
- Provides insights into potential epigenetic biomarkers for classifying breast cancer subtypes and grades.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...